- call +1-201-465-4211
- email sales@mrinsights.biz
Nilotinib in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
Scope of the Report:
This report focuses on the Tasigna Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Tasigna Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Novartis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
50mg
200mg
Other
Market Segment by Applications, can be divided into
Hospital
Drugs Store
Other
There are 15 Chapters to deeply display the global Tasigna Drug market.
Chapter 1, to describe Tasigna Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Tasigna Drug, with sales, revenue, and price of Tasigna Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Tasigna Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Tasigna Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Tasigna Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Tasigna Drug Introduction
1.2 Market Analysis by Type
1.2.1 50mg
1.2.2 200mg
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Drugs Store
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Tasigna Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Tasigna Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Tasigna Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Tasigna Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Tasigna Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Tasigna Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Tasigna Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Tasigna Drug Market Analysis by Regions
4.1 Global Tasigna Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Tasigna Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Tasigna Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Tasigna Drug Sales and Growth Rate (2013-2018)
4.3 Europe Tasigna Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Tasigna Drug Sales and Growth Rate (2013-2018)
4.5 South America Tasigna Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Tasigna Drug Sales and Growth Rate (2013-2018)
5 North America Tasigna Drug by Countries
5.1 North America Tasigna Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Tasigna Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Tasigna Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Tasigna Drug Sales and Growth Rate (2013-2018)
5.3 Canada Tasigna Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Tasigna Drug Sales and Growth Rate (2013-2018)
6 Europe Tasigna Drug by Countries
6.1 Europe Tasigna Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Tasigna Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Tasigna Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Tasigna Drug Sales and Growth Rate (2013-2018)
6.3 UK Tasigna Drug Sales and Growth Rate (2013-2018)
6.4 France Tasigna Drug Sales and Growth Rate (2013-2018)
6.5 Russia Tasigna Drug Sales and Growth Rate (2013-2018)
6.6 Italy Tasigna Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Tasigna Drug by Countries
7.1 Asia-Pacific Tasigna Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Tasigna Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Tasigna Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Tasigna Drug Sales and Growth Rate (2013-2018)
7.3 Japan Tasigna Drug Sales and Growth Rate (2013-2018)
7.4 Korea Tasigna Drug Sales and Growth Rate (2013-2018)
7.5 India Tasigna Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Tasigna Drug Sales and Growth Rate (2013-2018)
8 South America Tasigna Drug by Countries
8.1 South America Tasigna Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Tasigna Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Tasigna Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Tasigna Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Tasigna Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Tasigna Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Tasigna Drug by Countries
9.1 Middle East and Africa Tasigna Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Tasigna Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Tasigna Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Tasigna Drug Sales and Growth Rate (2013-2018)
9.3 UAE Tasigna Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Tasigna Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Tasigna Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Tasigna Drug Sales and Growth Rate (2013-2018)
10 Global Tasigna Drug Market Segment by Type
10.1 Global Tasigna Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Tasigna Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Tasigna Drug Revenue and Market Share by Type (2013-2018)
10.2 50mg Sales Growth and Price
10.2.1 Global 50mg Sales Growth (2013-2018)
10.2.2 Global 50mg Price (2013-2018)
10.3 200mg Sales Growth and Price
10.3.1 Global 200mg Sales Growth (2013-2018)
10.3.2 Global 200mg Price (2013-2018)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2013-2018)
10.4.2 Global Other Price (2013-2018)
11 Global Tasigna Drug Market Segment by Application
11.1 Global Tasigna Drug Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Drugs Store Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Tasigna Drug Market Forecast (2018-2023)
12.1 Global Tasigna Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Tasigna Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Tasigna Drug Market Forecast (2018-2023)
12.2.2 Europe Tasigna Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Tasigna Drug Market Forecast (2018-2023)
12.2.4 South America Tasigna Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Tasigna Drug Market Forecast (2018-2023)
12.3 Tasigna Drug Market Forecast by Type (2018-2023)
12.3.1 Global Tasigna Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Tasigna Drug Market Share Forecast by Type (2018-2023)
12.4 Tasigna Drug Market Forecast by Application (2018-2023)
12.4.1 Global Tasigna Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Tasigna Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Tasigna Drug Picture
Table Product Specifications of Tasigna Drug
Figure Global Sales Market Share of Tasigna Drug by Types in 2017
Table Tasigna Drug T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
